Caspofungin 70 mg powder for concentrate for solution for infusion

  • Company:

    Flynn Pharma Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 02 February 2023

File name

SmpC 70mg 2023 01 30.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Update in line with reference product

Updated on 23 August 2022

File name

SmPC 70mg 2022 05 05.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 23 August 2022

File name

ie-pil-mockup 70mg 2022 05 05.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Updated on 07 April 2021

File name

SmPC 70mg 2021 03 26.pdf

Reasons for updating

  • Change to section 9 - Date of first authorisation/renewal of the authorisation

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Addition of renewal date. No other changes made to the SmPC

Updated on 19 January 2021

File name

Capofungin PIL 70mg 2018.pdf

Reasons for updating

  • New PIL for new product

Updated on 19 January 2021

File name

Caspofungin SmPC 70mg 2018.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)